The administration of vitamin B12 to people with type 2 diabetes (T2DM) on long term metformin therapy

Not Applicable

Completed

• Conditions: Type 2 diabetes; Vitamin B12 deficiency; Metabolic and Endocrine - Diabetes; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12612001108808
• Lead Sponsor: Capital and Coast Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-10-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Type 2 diabetes
Metformin therapy
vitamin b12 levels below 220mmol/l

Exclusion Criteria

Pregnant or breastfeeding
Existing treated megaloblastic anaemia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
serum vitamin B12 level[3 and 6 months]

Secondary Outcome Measures

Name	Time	Method
neuropathy screening using Michigan neuropathy screening questionnaire[6 months]